PharmacyCodes



Urodin en es it fr

Categoria

Urodin Nombres de marca, Urodin Analogos

Urodin Marca los nombres de mezcla

  • No information avaliable

    • Urodin Formula quimica

    C8H6N4O5

    Urodin RX enlace

    http://www.rxlist.com/cgi/generic/nitro25m.htm

    Urodin FDA hoja

    Urodin MSDS (hoja de seguridad de materiales)

    Urodin MSDS

    Urodin Sintesis de referencia

    No hay información disponible

    Urodin Peso molecular

    238.157 g/mol

    Urodin Punto de fusion

    263 oC

    Urodin H2O Solubilidad

    79.5 mg / L

    Urodin Estado

    Solid

    Urodin LogP

    -0.04

    Urodin Formas de dosificacion

    Tableta

    Urodin Indicacion

    Para el tratamiento de la infección del tracto urinario

    Urodin Farmacologia

    Nitrofurantoína, un agente antibacteriano nitrofuranos, está disponible en forma microcristalina y macrocristalinas para tratar las infecciones del tracto urinario causada por muchas bacterias gram-negativas y algunas bacterias gram-positivas.

    Urodin Absorcion

    No hay información disponible

    Urodin Toxicidad

    No hay información disponible

    Urodin Informacion de Pacientes

    Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

    Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

    Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

    Urodin Organismos afectados

    Gram negativos y algunas bacterias gram positivas